Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jan '17 Jan '18 Jan '19 Jan '20 Jan '21 Jan '22 Jan '23 Jan '24 Jan '25 Jan '26
Revenue
550.54 690.56 862.21 1,104.08 1,465.07 1,850.78 2,155.06 2,363.67 2,746.62 3,195.31
Revenue Growth
34.53% 25.43% 24.86% 28.05% 32.70% 26.33% 16.44% 9.68% 16.20% 16.34%
Cost of Revenue
173.68 211.42 245.28 303.37 408.93 503.68 609.41 677.29 699.64 782.02
Gross Profit
376.86 479.14 616.93 800.71 1,056.14 1,347.10 1,545.66 1,686.38 2,046.98 2,413.29
R&D Expenses
96.74 132.02 158.78 209.90 294.22 382.04 520.28 629.03 693.08 767.39
SG&A Expenses
159.43 189.19 235.28 304.60 384.13 459.57 566.29 628.02 662.47 729.54
Operating Income
120.69 157.93 222.87 286.22 377.79 505.50 459.09 429.33 691.43 916.37
Non-operating Income/Expense
1.67 7.84 15.78 27.48 16.20 6.82 50.01 158.69 227.95 278.14
EBT
122.36 165.77 238.64 313.70 393.99 512.31 509.10 588.02 919.38 1,194.51
Income Tax Provision
44.78 14.59 8.81 12.58 14.00 84.92 21.39 62.32 205.24 285.60
Income after Tax
77.57 151.18 229.83 301.12 380.00 427.39 487.71 525.71 714.14 908.91
Dividends (Preferred)
0.00 — — — — — — — — —
Net Income Common
77.57 151.18 229.83 301.12 380.00 427.39 487.71 525.71 714.14 908.91
EPS (Basic)
0.51 1.01 1.59 2.03 2.52 2.79 3.14 3.27 4.41 5.55
EPS (Diluted)
0.47 0.92 1.47 1.90 2.36 2.63 3.00 3.22 4.32 5.44
Shares (Basic, Weighted)
135.70 140.31 144.24 147.80 150.67 153.25 155.39 160.53 161.88 163.67
Shares (Diluted, Weighted)
147.58 153.68 156.12 158.30 160.73 162.28 162.44 163.49 165.23 167.00
Gross Margin
68.45% 69.38% 71.55% 72.52% 72.09% 72.79% 71.72% 71.35% 74.53% 75.53%
EBIT Margin
21.92% 22.87% 25.85% 25.92% 25.79% 27.31% 21.30% 18.16% 25.17% 28.68%
EBT margin
22.22% 24.01% 27.68% 28.41% 26.89% 27.68% 23.62% 24.88% 33.47% 37.38%
Net Profit Margin
14.09% 21.89% 26.66% 27.27% 25.94% 23.09% 22.63% 22.24% 26.00% 28.44%
Free Cash Flow Margin
24.79% 32.16% 34.91% 39.22% 37.03% 40.54% 35.59% 37.45% 38.94% 43.38%
EBITDA
150.55 190.24 252.88 323.33 431.06 565.26 506.68 453.62 721.90 961.07
EBIT
120.69 157.93 222.87 286.22 377.79 505.50 459.09 429.33 691.43 916.37
Income from Continuous Operations
77.57 151.18 229.83 301.12 380.00 427.39 487.71 525.71 714.14 908.91
Consolidated Net Income/Loss
77.57 151.18 229.83 301.12 380.00 427.39 487.71 525.71 714.14 908.91
EPS (Basic, from Continuous Ops)
0.57 1.08 1.59 2.04 2.52 2.79 3.14 3.27 4.41 5.55
EPS (Basic, Consolidated)
0.57 1.08 1.59 2.04 2.52 2.79 3.14 3.27 4.41 5.55
EPS (Diluted, from Cont. Ops)
0.53 0.98 1.47 1.90 2.36 2.63 3.00 3.22 4.32 5.44
Shares (Diluted, Average)
147.58 153.68 156.12 158.30 160.73 162.28 162.44 163.49 165.23 167.00
EPS (Diluted, Consolidated)
0.53 0.98 1.47 1.90 2.36 2.63 3.00 3.22 4.32 5.44
EBITDA Margin
27.35% 27.55% 29.33% 29.28% 29.42% 30.54% 23.51% 19.19% 26.28% 30.08%
Operating Cash Flow Margin
26.16% 33.80% 36.05% 39.61% 37.63% 41.30% 36.22% 38.56% 39.69% 44.29%

Fold the line items

In millions of $ except per-share values · columns are period end dates